Yamashita M, Ukai-Tadenuma M, Miyamoto T, Sugaya K, Hosokawa H, Hasegawa A, Kimura M, Taniguchi M, DeGregori J, Nakayama T, « Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci », J Biol Chem, vol. 279, no 26, , p. 26983–90 (PMID15087456, DOI10.1074/jbc.M403688200)
Kouros-Mehr Hosein, Slorach EM, Sternlicht MD, Werb Z, « GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland », Cell, vol. 127, no 5, , p. 1041–55 (PMID17129787, PMCID2646406, DOI10.1016/j.cell.2006.09.048)
Koboldt DC, Fulton RS, McLellan MD, et al., « Comprehensive molecular portraits of human breast tumours », Nature, vol. 490, no 7418, (PMID23000897, PMCID3465532, DOI10.1038/nature11412)
Wilson BJ, Giguere V, « Meta-analysis of human cancer microarrays reveals that GATA3 is integral to the estrogen receptor alpha pathway », Mol Cancer, vol. 7, , p. 49 (PMID18533032, PMCID2430971, DOI10.1186/1476-4598-7-49)
Dydensborg AB, Rose AA, Wilson BJ, Grote D, Paquet M, Giguère V, Siegel PM, Bouchard M., « GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis », Oncogene, vol. 28, no 29, , p. 2634–42 (PMID19483726, DOI10.1038/onc.2009)
Sanga S, Broom BM, Cristini V, Edgerton ME, « Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family », BMC Medical Genomics, vol. 2, , p. 59 (PMID19747394, PMCID2753593, DOI10.1186/1755-8794-2-59)modifier
Kouros-Mehr Hosein, Kim JW, Bechis SK, Werb Z, « GATA-3 and the regulation of the mammary luminal cell fate », Curr. Opin. Cell Biol., vol. 20, no 2, , p. 164–70 (PMID18358709, PMCID2397451, DOI10.1016/j.ceb.2008.02.003)
Jacquemier J, Charafe-Jauffret E, Monville F, Esterni B, Extra JM, Houvenaeghel G, Xerri L, Bertucci F, Birnbaum D, « Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer », Breast Cancer Res., vol. 11, no 2, , R23 (PMID19405945, PMCID2688952, DOI10.1186/bcr2249)
Albergaria A, Paredes J, Sousa B, Milanezi F, Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW, Lunet N, Schmitt F, « Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours », Breast Cancer Res., vol. 11, no 3, , R40 (PMID19549328, PMCID2716509, DOI10.1186/bcr2327)
Kouros-Mehr Hosein, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z, « GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model », Cancer Cell, vol. 13, no 2, , p. 141–52 (PMID18242514, PMCID2262951, DOI10.1016/j.ccr.2008.01.011)
McCune K, Bhat-Nakshatri P, Thorat MA, Nephew KP, Badve S, Nakshatri H, « Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet », Cancer Res., vol. 70, no 2, , p. 685–96 (PMID20068169, PMCID2807987, DOI10.1158/0008-5472.CAN-09-1530)
Ono Y, Fukuhara N, Yoshie O, « Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL », J. Biol. Chem., vol. 272, no 7, , p. 4576–81 (PMID9020185, DOI10.1074/jbc.272.7.4576)
Joulin V, Bories D, Eleouet JF, Labastie MC, Chretien S, Mattei MG, Romeo PH, « A T-cell specific TCR delta DNA binding protein is a member of the human GATA family », EMBO J, vol. 10, no 7, , p. 1809–16 (PMID2050118, PMCID452855)
Yamashita M, Ukai-Tadenuma M, Miyamoto T, Sugaya K, Hosokawa H, Hasegawa A, Kimura M, Taniguchi M, DeGregori J, Nakayama T, « Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci », J Biol Chem, vol. 279, no 26, , p. 26983–90 (PMID15087456, DOI10.1074/jbc.M403688200)
Kouros-Mehr Hosein, Slorach EM, Sternlicht MD, Werb Z, « GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland », Cell, vol. 127, no 5, , p. 1041–55 (PMID17129787, PMCID2646406, DOI10.1016/j.cell.2006.09.048)
Koboldt DC, Fulton RS, McLellan MD, et al., « Comprehensive molecular portraits of human breast tumours », Nature, vol. 490, no 7418, (PMID23000897, PMCID3465532, DOI10.1038/nature11412)
Wilson BJ, Giguere V, « Meta-analysis of human cancer microarrays reveals that GATA3 is integral to the estrogen receptor alpha pathway », Mol Cancer, vol. 7, , p. 49 (PMID18533032, PMCID2430971, DOI10.1186/1476-4598-7-49)
Dydensborg AB, Rose AA, Wilson BJ, Grote D, Paquet M, Giguère V, Siegel PM, Bouchard M., « GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis », Oncogene, vol. 28, no 29, , p. 2634–42 (PMID19483726, DOI10.1038/onc.2009)
Sanga S, Broom BM, Cristini V, Edgerton ME, « Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family », BMC Medical Genomics, vol. 2, , p. 59 (PMID19747394, PMCID2753593, DOI10.1186/1755-8794-2-59)modifier
Kouros-Mehr Hosein, Kim JW, Bechis SK, Werb Z, « GATA-3 and the regulation of the mammary luminal cell fate », Curr. Opin. Cell Biol., vol. 20, no 2, , p. 164–70 (PMID18358709, PMCID2397451, DOI10.1016/j.ceb.2008.02.003)
Jacquemier J, Charafe-Jauffret E, Monville F, Esterni B, Extra JM, Houvenaeghel G, Xerri L, Bertucci F, Birnbaum D, « Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer », Breast Cancer Res., vol. 11, no 2, , R23 (PMID19405945, PMCID2688952, DOI10.1186/bcr2249)
Albergaria A, Paredes J, Sousa B, Milanezi F, Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW, Lunet N, Schmitt F, « Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours », Breast Cancer Res., vol. 11, no 3, , R40 (PMID19549328, PMCID2716509, DOI10.1186/bcr2327)
Kouros-Mehr Hosein, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z, « GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model », Cancer Cell, vol. 13, no 2, , p. 141–52 (PMID18242514, PMCID2262951, DOI10.1016/j.ccr.2008.01.011)
McCune K, Bhat-Nakshatri P, Thorat MA, Nephew KP, Badve S, Nakshatri H, « Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet », Cancer Res., vol. 70, no 2, , p. 685–96 (PMID20068169, PMCID2807987, DOI10.1158/0008-5472.CAN-09-1530)
Ono Y, Fukuhara N, Yoshie O, « TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3 », Mol. Cell. Biol., vol. 18, no 12, , p. 6939–50 (PMID9819382, PMCID109277)
Ono Y, Fukuhara N, Yoshie O, « Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL », J. Biol. Chem., vol. 272, no 7, , p. 4576–81 (PMID9020185, DOI10.1074/jbc.272.7.4576)
wikipedia.org
fr.wikipedia.org
Sanga S, Broom BM, Cristini V, Edgerton ME, « Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family », BMC Medical Genomics, vol. 2, , p. 59 (PMID19747394, PMCID2753593, DOI10.1186/1755-8794-2-59)modifier
